RT Journal Article
SR Electronic
T1 Using Disability-Adjusted Life Years to assess the burden of road traffic injuries in Nay Pyi Taw, Myanmar
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.04.26.20080325
DO 10.1101/2020.04.26.20080325
A1 Win Ei Ei Thaw
A1 Wantanee Phanprasit
A1 Kwanjai Amnatsatsue
A1 Ariya Bunnagamchairat
A1 Kanitta Bundhamcharoen
YR 2020
UL http://medrxiv.org/content/early/2020/04/29/2020.04.26.20080325.abstract
AB Background Road traffic injury (RTI) is growing public health problem in Myanmar. In addition, every count in road crush is followed by remarkable burdens in the community. In this study, burden of disease (BOD) approach is used to quantify this hidden problem in the studied area.Aim/Objective/Purpose To assess the burden of traffic injuries in Nay Pyi Taw Union Territory, MyanmarMethods This cross-sectional study analyzed 16,338 traffic injury victims in injury registry, from 2012 to 2016. The burden was estimated by disability-adjusted life years (DALYs). The analysis was disaggregated by sex, age and type of road users, as well as expressed the rate by per 100,000 population.Results/Outcomes It was 60,962 DALYs in total for the studied period, with the rate of 1050.85 per 100,000 population. Although premature death in road crash was only 6.2% in the study, it attributed 87.8% of total burden. Total DALYs contributed by male were three-times higher than female. Nearly half of burden came from the young and productive population of 15-29 years. The highest DALYs rate was seen in the 20-24 years in male and 30-34 years in female. The highest RTI burden was due to motorized two-wheelers, with 69.4% of total DALYs.Conclusion This study initiates usefulness of local data from injury registry to calculate the burden of injury. The findings highlight a huge burden of traffic injuries in the community, focusing on the hidden contribution of fatal cases and the vulnerability of young adult, male and motorcyclists in traffic accidents.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialIt is not clinical trial.Funding StatementThere is no funding for publication.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data that support the findings of this study are available on request from the corresponding author, email; wineieithaw{at}outlook.com.